ROIV
Roivant Sciences Ltd
36.10$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.26 | -0.25 | -0.14 | -0.36 | -0.36 | -0.29 | -0.24 | -0.30 | -0.27 | -0.28 | -0.20 | -0.37 | -1.12 | |
| 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.04 | 0.00 | 0.03 | |
| 0.06 | 0.06 | 0.06 | 0.10 | 0.10 | 0.12 | 0.12 | 0.12 | 0.12 | 0.15 | 0.10 | 0.12 | 0.48 | |
| 0.12 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | -0.07 | 0.05 | -0.05 | 0.01 | 0.01 | -0.74 | 0.01 | -0.80 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | |
| -0.05 | 6.20 | 0.01 | -4.48 | -4.48 | 0.63 | 1.52 | -1.60 | 0.18 | 0.21 | 0.17 | 0.39 | 0.95 | |
| 0.01 | – | 0.01 | – | – | – | – | – | – | – | – | – | – | |
| -0.28 | 0.00 | 0.28 | -0.14 | -0.14 | -0.34 | -0.42 | -0.31 | 0.00 | 0.00 | -0.14 | -0.29 | -0.44 | |
| -0.01 | – | – | – | 0.00 | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 0.27 | 0.28 | -0.04 | -0.15 | -0.15 | -0.38 | -0.25 | -0.28 | 0.09 | 0.41 | -0.04 | -0.54 | -0.09 | |
| -0.03 | 6.23 | -0.22 | -4.98 | -4.98 | -0.04 | 1.02 | -2.17 | 0.00 | 0.35 | -0.07 | -0.51 | -0.26 | |
| -0.26 | -0.25 | -0.14 | -0.36 | -0.36 | -0.29 | -0.25 | -0.31 | -0.28 | -0.27 | -0.20 | -0.37 | -1.13 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.